Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
- Arthur C. ButcherBSX
- Cathy R. SmithBSX
- Cheryl PegusBSX
- Christophe Pierre WeberBSX
- David C. HabigerBSX
- David S. WichmannBSX
- Ellen M. ZaneBSX
- Emily WoodworthBSX
- Jessica L. MegaBSX
- Jonathan MonsonBSX
- Joseph Michael FitzgeraldBSX
- Michael F. MahoneyBSX
- Miriam O'SullivanBSX
- Padraig Andrew O'ConnorBSX
- Susan E. MoranoBSX
- Vance R. BrownBSX
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 31, 2026 | BSX | Buy | 5,000 | $45.48 | $227K |
| May 20, 2026 | BSX | Buy | 3,580 | $56.68 | $203K |
| Jul 25, 2025 | BSX | Sale | 4,000 | $106.03 | $424K |
| May 29, 2025 | BSX | Sale | 4,000 | $104.59 | $418K |
| Feb 11, 2025 | BSX | Sale | 12,000 | $105.48 | $1.3M |
| Nov 21, 2024 | BSX | Sale | 4,877 | $91.63 | $447K |
| May 2, 2024 | CVS | Buy | 1,000 | $53.88 | $54K |
| Apr 26, 2024 | BSX | Sale | 9,818 | $73.29 | $720K |
| Feb 13, 2024 | BSX | Sale | 7,000 | $65.03 | $455K |
| Nov 3, 2023 | CVS | Buy | 2,000 | $70.47 | $141K |
| Feb 10, 2022 | CVS | Buy | 1,000 | $105.90 | $106K |
| Aug 5, 2021 | CVS | Buy | 3,000 | $79.55 | $239K |
| Feb 17, 2021 | CVS | Buy | 3,000 | $72.00 | $216K |
| Mar 8, 2019 | CVS | Buy | 2,000 | $52.80 | $106K |
| Mar 1, 2019 | CVS | Buy | 4,000 | $58.27 | $233K |
SEC reporting-owner ID (CIK) 1221783 · all filings on EDGAR